RA Capital Management’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$22.8M Hold
8,889,000
– – 0.23% 55
2026
Q2
$28.8M Buy
+8,889,000
New +$26M 0.25% 54

Other funds holding EDIT

RA Capital Management's EDIT Position: Q3 2026 in Review

RA Capital Management held its Editas Medicine (EDIT) position steady in Q3 2026 at 8,889,000 shares worth $22.8M. The position accounts for 0.23% of the portfolio, ranked #55.

RA Capital Management first reported a position in EDIT in Q2 2026 and has held it in 2 quarters since. The position peaked at $28.8M in Q2 2026. 219 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.

  • RA Capital Management held 8,889,000 shares of Editas Medicine worth $22.8M as of Q3 2026.
  • RA Capital Management left its Editas Medicine share count unchanged in Q3 2026.
  • Editas Medicine made up 0.23% of RA Capital Management's portfolio in Q3 2026, its #55 holding.
  • RA Capital Management first reported a position in Editas Medicine in Q2 2026 and has held it in 2 quarters since.
  • RA Capital Management's Editas Medicine position peaked at $28.8M in Q2 2026.
  • 219 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.

Based on RA Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.